Infliximab Therapeutic monitoring by tryptic peptide LC-MS/MS method improvements lead to improved accuracy with decreased imprecision and turnaround time

Paula M. Ladwig, Ann L. Rivard, Alex Barbeln, Anthony Maus, David L. Murray, Melissa R. Snyder, Maria A.V. Willrich

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Infliximab Therapeutic monitoring by tryptic peptide LC-MS/MS method improvements lead to improved accuracy with decreased imprecision and turnaround time'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds